Filter
1575
Text search:
pharmaceutical
needs
Featured
142
426
Language
Document type
821
302
234
78
73
21
19
12
5
5
3
2
Countries / Regions
67
66
65
58
48
41
40
36
32
31
23
22
22
21
21
21
21
20
20
18
17
16
15
14
13
13
12
11
11
10
9
9
7
7
7
7
6
6
6
6
6
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
671
99
77
51
35
26
11
2
Toolboxes
151
150
120
89
88
73
46
37
33
32
32
29
28
24
21
13
10
7
7
7
4
3
2
2
Towards the Peoples Health Assembly Book -4
Capability and Performance
AUDIT REPORT NO. 9-000-11-001-P | February 24, 2011
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
PMPB/INS-GUIDE/04
Doc. No.: INS/GDL/001-(Annexes)
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Guidelines for social mobilization
TB and poverty; TB and children; TB and women; TB, migrants and refugees; TB and prisons
WHO/CDS/STB/2001.9
Original: English; Distribution: Limited
